Skip to main content
. 2023 Mar 27;2023(3):CD009885. doi: 10.1002/14651858.CD009885.pub3
Sample calculation
Ethics approval
Inclusion of methylphenidate responders only/exclusion of methylphenidate non‐responders/children who have previously experienced adverse events while taking methylphenidate
Any withdrawals due to adverse events
Comments from trial authors
Key conclusions of trial authors
Comments from review authors
Supplemental information/data received through personal email correspondence with trial authors in *month* 2014